O=C(NCCc1cn[nH]c1)C1CCC(=O)N(CCc2cccc(F)c2)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?